Advocacy intelligence hub — real-time data for patient organizations
Sarepta Therapeutics, Inc. — PHASE3
Sarepta Therapeutics, Inc. — PHASE1
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Beta-sarcoglycan-related limb-girdle muscular dystrophy R4 news →
Nicholas Johnson, MD
Virginia Commonwealth University
📍 Richmond, Virginia
Jerry R Mendell, M.D., MD
Nationwide Children's Hospital
📍 COLUMBUS, OH
Linda Lowes, PT PhD
Nationwide Children's Hospital
View all Beta-sarcoglycan-related limb-girdle muscular dystrophy R4 specialists →